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Introduction
Monitoring plays an important role in the current 
management of patients with acute respiratory failure. 
However, unlike monitoring of other organs and func-
tions, monitoring of respiratory function in the critically 
ill sometimes lacks deﬁ nition regarding which ‘signals’ 
and ‘derived variables’ should be prioritized as well as 
speciﬁ cs related to timing (continuous versus inter mittent) 
and modality (static versus dynamic). In this consensus 
paper, we summarize current modes of respira tory moni-
tor ing and their potential practical appli ca tions (Table 1). 
Th e amount of text devoted to each modality varies 
according to perceived familiarity with the technique: 
more text is dedicated to novel strategies and those with 
newer indications.
Monitoring systems
1. Gas exchange
Pulse oximetry and transcutaneous carbon dioxide 
monitoring
Pulse oximetry is widely used in anesthesiology and inten-
sive care and, in intensive care unit (ICU) patients, has a 
bias of less than 1% and a good to moderate precision [1]; 
accuracy decreases in hypoxemia (oxygen saturation as 
measured by pulse oximetry, or SpO2, of less than 90%). 
Among the intrinsic limitations of pulse oximetry are 
that it is insensitive to changes in arterial partial pressure 
of oxygen (PaO2) at high PaO2 levels and cannot distin-
guish between normal hemoglobin and methemo globin 
or carboxyhemoglobin. Nail polish may aﬀ ect the 
measure ment by about 2% (not really clinically relevant) 
[2], and pulse oximetry can slightly underestimate arterial 
oxygen saturation (SaO2) in patients with darkly pig-
mented skin [3]. Altered skin perfusion and carboxy-
hemoglobin can also lead to inaccurate pulse oximetry 
readings. Th e type of probe can make a diﬀ erence, and 
accuracy is usually better for ﬁ nger than for earlobe 
probes [4]. False alarms are common, usually because of 
motion artifacts, particularly in the pediatric population.
Pulse oximetry readings should be used to provide an 
early warning sign, decreasing the need for blood gas 
measurements. In a randomized controlled trial in more 
than 20,000 surgical patients [5], pulse oximetry was not 
associated with decreased postoperative complications 
or mortality, but 80% of the anesthesiologists felt more 
secure when a pulse oximeter was used!
Transcutaneous partial pressure of carbon dioxide 
(PCO2) monitors have also been developed with probes 
generally placed on the earlobe. Precision of trans cutaneous 
PCO2 measurements has improved as tech nology has 
advanced, and devices have become smaller but still need 
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regular recalibration [6]. Th eir place in the respiratory 
monitoring of ICU patients has not yet been deﬁ ned.
Volumetric capnography and dead space calculation
Th e expiratory capnogram provides qualitative informa-
tion on the waveform patterns associated with mecha-
nical ventilation and quantitative estimation of expired 
CO2. Capnography tracings show three phases (Figure 1) 
[7]: phase I contains gas from the apparatus and anatomic 
dead space (airway), phase II represents increasing CO2 
concentration resulting from progressive emptying of 
alveoli, and phase III represents alveolar gas. Phase III is 
often referred to as the plateau and its appearance is 
relatively ﬂ at or has a small positive slope; the highest 
point is the end-tidal PCO2 (PetCO2). Th e almost rectan-
gular shape of the expired capnogram depends on the 
homogeneity of the gas distribution and alveolar venti-
lation. Lung heterogeneity creates regional diﬀ erences in 
CO2 concentration, and gas from high V/Q regions ﬁ rst 
appears in the upper airway during exhalation. Th is 
sequential emptying contributes to the rise of the alveolar 
plateau; the greater the V/Q heterogeneity, the steeper 
the expired CO2 slope. Accordingly, the slope of the 
alveolar plateau has been shown to correlate with the 
severity of airﬂ ow obstruction [8].
Physiologic dead space (Vdphys) can be easily calculated 
from the Enghoﬀ  modiﬁ cation of the Bohr equation by 
using arterial partial pressure of carbon dioxide (PaCO2) 
with the assumption that PaCO2 is similar to alveolar 
PCO2:
Vdphys / VT = (PaCO2 − PECO2) / PaCO2,
where VT is the tidal volume and PECO2 is the partial 
pressure of CO2 in mixed expired gas and is equal to the 
mean expired CO2 fraction multiplied by the diﬀ erence 
between the atmospheric pressure and the water vapor 
pressure. Vdphys is increased in acute respiratory distress 
syndrome (ARDS), and a high dead space fraction 
represents an impaired ability to excrete CO2 because of 
any kind of V/Q mismatch. Several authors [9,10] have 
demonstrated that increased Vdphys values are indepen-
dently associated with an increased risk of death in these 
patients.
Table 1. Summary of the diff erent monitoring techniques
 Continuous versus   
Monitoring technique intermittent Specifi c situations Potential usefulness Limitations
Pulse oximetry Continuous All patients receiving MV Detection of hypoxemia
Ventilator pressures Continuous All patients receiving volume-
controlled modes
Less reliable when patient is 
breathing actively
Ventilator traces Continuous All patients receiving MV Clinicians need to learn how 
to read traces (no automatic 
detection)
Respiratory mechanics Intermittent Passive patients ARDS, COPD Less reliable when patient is 
awake
Pressure/volume curves Intermittent Passive patients ARDS Complex and need sedation 
and relatively homogeneous 
lungs
Work of breathing, pressure-
time product
Intermittent Respiratory distress, ventilator 
setting, weaning
Research No automated measurement; 
needs esophageal pressure
Extravascular lung water Intermittent Pulmonary edema Diagnosis of pulmonary edema Complex and needs invasive 
devices
Lung volumes Intermittent ARDS Could help to defi ne risks of 
ventilation and assess recruitment
Need a passive patient
Electric impedance 
tomography
Continuous ARDS Could help to visualize regional 
ventilation
Needs a specifi c tool
Hemodynamic monitoring Continuous or 
intermittent
Patients who have 
hemodynamic impairment 
and who are receiving MV
Helps to understand hypoxemia 
and its consequences
More or less invasive
Volumetric capnography Continuous ARDS Complex analysis
Esophageal and 
transpulmonary pressure
Continuous or 
intermittent
ARDS Could help to titrate ventilator 
pressures
Complex interpretation and 
diffi  cult placement
Diaphragmatic 
electromyography
Continuous Patients receiving assisted 
ventilation
Needs specifi c catheter, no 
absolute value
ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; MV, mechanical ventilation.
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Since Vdphys/VT measures the fraction of each tidal 
breath that is wasted on alveolar dead space (Vdalv) and 
airway dead space (Vdaw), the Vdaw must be subtracted 
from Vdphys/VT to obtain the Vdalv/VT [11]. By using the 
PetCO2 instead of PECO2 in the equation, the Vdalv can be 
calculated. Equating the alveolar PCO2 to the arterial 
PaCO2 is, however, valid only in healthy subjects. In 
patients with high right-to-left shunt, PaCO2 is higher 
than alveolar PCO2 because of the shunted blood with 
high PvCO2 (partial pressure of carbon dioxide in mixed 
venous blood). Without correction [12], it must be 
remembered that a high dead space also includes the 
shunt eﬀ ect.
PaCO2 can be grossly estimated by PetCO2. Monitoring 
PetCO2 can also help to track PaCO2 when changes in 
PaCO2 are to be avoided (especially in critically ill, 
neurological patients with normal lungs). Th e gradient 
between PaCO2 and PetCO2 widens in ARDS and corre-
lates across the diﬀ erent levels of Vdphys [13]. Th e diﬀ er-
ence between PaCO2 and PetCO2 is reduced by using the 
maximal values of PetCO2 over time [14].
In patients with sudden pulmonary vascular occlusion 
due to pulmonary embolism, the resultant V/Q mismatch 
produces an increase in Vdalv. When volumetric capno-
graphy is used as a bedside technique, the association of a 
normal D-dimer assay result plus a normal Vdalv is a 
highly sensitive screening test to rule out the diagnosis of 
pulmonary embolism [15]. Volumetric capnography has 
also been shown to be an excellent tool for monitoring 
thrombolytic eﬃ  cacy in patients with pulmonary 
embolism [16].
When the application of positive end-expiratory 
pressure (PEEP) results in global lung recruitment, 
physio logic and alveolar dead space decrease [17]; the 
reverse is true when PEEP application results in lung 
overdistension [18]. Th erefore, volumetric capnography 
may also be helpful to identify overdistension or better 
alveolar gas diﬀ usion [19].
In summary, volumetric capnography has important 
potential for monitoring the diﬃ  cult-to-ventilate patient. 
Volumetric capnography needs sophisticated equipment 
and this has limited its widespread use.
Blood gases
Th e PaO2/inspired fraction of oxygen (PaO2/FiO2) ratio is 
still the most frequently used variable for evaluating the 
severity of lung failure and is included in the current 
deﬁ nition of acute lung injury/ARDS [20]. Th e PaO2/FiO2 
ratio is often a curvilinear (U-shaped) relationship, being 
at its lowest for moderate ranges of FiO2, depending on 
the shunt level, the hemoglobin value, and the arterio-
venous diﬀ erence in O2 content [21-23]. For a given 
PaO2/FiO2 ratio, the higher the FiO2, the poorer the 
prognosis [24]. In patients with ARDS, the PaO2/FiO2 
ratio is dependent on the PEEP level and can be a 
surrogate, though imperfect, marker of recruitment [25]. 
Hemodynamic status (via the mixed venous oxygen 
tension, or PvO2) and intracardiac shunt (patent foramen 
ovale) also inﬂ uence the PaO2/FiO2 ratio [26]. Despite its 
limitations, this ratio remains the most commonly used 
means of assessing severity of lung disease. Th e oxygen 
index ([mean airway pressure  × FiO2  × 100]/PaO2) 
accounts better for the inﬂ uence of ventilator pressures 
on oxygenation value [27].
PaCO2-related variables are tightly correlated to 
outcome [28] and to lung structural changes [29] 
sometimes better than oxygen-related variables (such as 
shunt fraction) [30,31].
Extravascular lung water
Extravascular lung water (EVLW) is a quantitative 
measure of pulmonary edema and is correlated, in multi-
ple patient populations, to mortality [32]. Normal values 
are 5 to 7 mL/kg (indexed to predicted body weight), and 
quantities above 10  mL/kg are associated with adverse 
clinical outcomes [33].
Indicator dilution techniques for measuring EVLW are 
available for bedside use in critically ill patients. Th e 
single-indicator technique is now well validated and 
oﬀ ers the additional value of simultaneously measuring 
cardiovascular performance (cardiac output, ﬂ uid res-
ponsive ness, and ﬁ lling volumes). Current technology 
uses an injection of cold saline into the right atrium and 
assesses transpulmonary thermodilution in the arterial 
system by using a femoral or brachial catheter. 
Figure 1. The three phases of capnography tracings. Phase I 
contains gas from the apparatus and anatomic dead space (airway), 
phase II represents increasing carbon dioxide concentration resulting 
from progressive emptying of alveoli, and phase III represents alveolar 
gas. The highest point of phase III is the end-tidal partial pressure of 
carbon dioxide (PetCO2). PaCO2, arterial partial pressure of carbon 
dioxide; PCO2, partial pressure of carbon dioxide.
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Limita tions of the technique include requirements for 
good indicator mixing without loss and for constant 
blood ﬂ ow and temperature. EVLW can be assessed only 
in perfused areas of the lung [34].
EVLW measurements may be used in combination 
with other cardiovascular and pulmonary parameters to 
diagnose pulmonary edema. Complementary informa-
tion from indicator dilution techniques, such as cardiac 
ﬁ lling volumes, helps to diﬀ erentiate between hydro-
static/cardiogenic pulmonary edema and permeability 
edema [35]. Although repeated measures could be used 
to assess response to interventions [35], it is unclear how 
fast the response time is and whether this technique can 
be used as a tool to guide therapy.
2. Respiratory mechanics
Compliance and resistance
Monitoring airway pressures can provide important 
information. In ﬂ ow (volume)-controlled mode, peak 
airway pressure is determined by both resistance and 
compliance – a high peak pressure with a much lower 
plateau pressure indicates a high resistance related 
either to the patient (bronchospasm) or to the 
equipment (small-diameter endotracheal tube [ETT] or 
narrow or obstructed tubing). Plateau pressure 
measurement requires a pause at end-insuﬄ  ation of at 
least 200 to 500 ms with a quasi-steady pressure. Longer 
pauses may be required to precisely estimate lung 
homogeneities or pendelluft phenomena but their 
clinical role is unclear. Patients must be relaxed during 
this measurement.
Compliance is easily calculated as the ratio between VT 
and plateau pressure minus PEEP (Figure 2). Elastance is 
the reverse of compliance (how much pressure we need 
for a given volume). A low compliance-high elastance 
reﬂ ects mainly a small aerated lung available for ventila-
tion. High plateau pressure may be related to either low 
compliance or high end-expiratory pressure (ﬂ ow limita-
tion or dynamic hyperinﬂ ation). Peak airway pressure is 
very sensitive to changes in respiratory mechanics; 
performing end-inspiratory and end-expiratory pauses 
may allow the exact cause of a high peak airway pressure 
to be determined. Compliance is not easily assessed on 
pressure-predetermined modes, especially when the 
expiratory phase starts before ﬂ ow stops. In such cases, 
an end-inspiratory occlusion test should be performed to 
assess plateau pressure, even in time-cycled pressure-
limited modes.
Measurements of respiratory mechanics are simple to 
perform and provide useful and relevant information for 
severity assessment and ventilator management. Th ey are 
really reliable only in passive conditions of ventilation, in 
which plateau pressure monitoring is essential for 
adequate ventilatory management.
Pressure/volume curves
Th e study of lung mechanics is particularly helpful in 
patients with ARDS. Study of pressure/volume (P/V) 
curves requires insuﬄ  ations at very low ﬂ ow to avoid the 
inﬂ uence of the resistive components [36-38]. Th e accent 
has often been placed on identiﬁ cation of the lower (LIP) 
[39] and upper (UIP) [40] inﬂ ection points on the P/V 
curve, but this approach has limitations. First, identifying 
the LIP or UIP is sometimes diﬃ  cult. Second, recruit-
ment takes place throughout the P/V curve [41,42], and 
recruitment and overdistension can occur at the same 
time. Th ird, application of an optimal PEEP level should, 
ideally, be assessed from the expiratory rather than the 
inspiratory limb of this relationship.
Interpretation of P/V curves is diﬃ  cult in the presence 
of altered chest compliance [43]. Chest wall compliance 
may be decreased in cases of increased abdominal 
pressure, thoracic trauma, large pleural eﬀ usions, obesity, 
and so on. Measuring esophageal pressure (surrogate of 
pleural pressure) allows pressure dissipated through the 
chest wall to be diﬀ erentiated from pressure distending 
the lungs (transpulmonary pressure). In medical patients, 
the chest wall has little to modest impact on respiratory 
pressures [43]; whether this is diﬀ erent in patients with 
abdominal surgery or obesity needs further study. Never-
theless, the concept remains that ventilating down to too 
low a pressure may result in so-called atelectrauma 
(open ing and closing the alveoli repeatedly), and inﬂ ating 
the lungs too much when most of the recruitment has 
already occurred may result in overdistension.
Figure 2. Analysis of airway pressures and fl ow during volume-
controlled mechanical ventilation. The diff erence between peak 
or maximal pressure (Pmax) and plateau pressure (Pplat) defi nes the 
resistive pressure, whereas the diff erence between Pplat and positive 
end-expiratory pressure (PEEP) defi nes the elastic pressure. Analysis 
of the airway pressure shape during the phase of constant fl ow 
infl ation (removing initial and fi nal parts) can be used to calculate the 
stress index (arrow).
Flow (volume) controlled ventilation
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Th e diﬀ erence between the inspiratory and expiratory 
parts of the P/V curve are related, in part, to hysteresis 
[44], which reﬂ ects whether PEEP should be increased or 
not. If the two limbs of the curve are superimposed, 
increasing PEEP will not help; if there is a large diﬀ erence 
in volume between inspiratory and expiratory portions, 
PEEP may help (Figure 3). Quantiﬁ cation of recruitment 
requires multiple P/V curves [45], and, although P/V 
curves are now more frequently available on commercial 
ventilators, the lack of an estimate of recruitment still 
limits clinical usefulness. Th e P/V curve technique has 
thus been used mainly as a research tool.
During constant ﬂ ow insuﬄ  ations, a stress index 
(Figure 2) can be calculated from the shape of the airway 
pressure-versus-time curve (which is essentially the 
opposite of the P/V curve since during constant ﬂ ow time 
equals volume) [46]. If there is down ward concavity, 
compliance improves over time (stress index of less than 
1), reﬂ ecting tidal recruitment of collapsed alveoli; if the 
curve is straight (stress index of 1), compliance is 
constant, reﬂ ecting ventilation of the normal lung; and if 
there is upward concavity (stress index of greater than 1), 
it means that compliance is decreasing over time during 
insuﬄ  ations, reﬂ ecting overinﬂ ation. A stress index of 
less than 1 may suggest a need to increase PEEP; a stress 
index of greater than 1 may suggest a need to reduce VT 
[47]. Th e same limitations described for the P/V curve 
(that is, recruitment and overdistension) apply to this 
kind of analysis. Th e clinical place and reliability of the 
stress index are still debated [48].
Diaphragmatic function
Mechanical ventilation has been associated with 
ventilator-induced diaphragmatic dysfunction [49]. Dia-
phragmatic function can be altered early and is related to 
the duration of mechanical ventilation [50]. Th e trans-
diaphragmatic pressure diﬀ erence (gastric minus esopha-
geal pressure) reﬂ ects diaphragmatic func tion but only in 
patients who have spontaneous ventila tory breaths and 
who can cooperate. Magnetic phrenic stimulation can be 
used to assess diaphragmatic function [51] as a non-
invasive method in sedated and non-sedated patients but 
remains a test of respiratory muscle function rather than 
a monitoring tool and is used mainly in research.
Measurements of diaphragmatic electrical activity are 
now possible and have been used  to drive the ventilator 
during neurally adjusted ventilatory assist [52]. Although 
it does not provide absolute values, monitoring diaphrag-
matic electrical activity may be of potential interest to 
detect patient-ventilator asynchrony.
Pressure and fl ow monitoring to assess asynchrony
A considerable amount of information can be obtained 
from pressure and ﬂ ow time curve analysis [53]. Th e 
airﬂ ow trace can reveal the presence of auto-PEEP, when 
ﬂ ow does not return to zero at the end of expiration 
(Figure  4). Dyssynchrony can be caused by poor or 
delayed ventilator triggering or cycling or both. Excessive 
levels of pressure support may result in ineﬀ ective 
triggering because they are associated with long 
inspiratory times and intrinsic PEEP [54], and insuﬃ  cient 
assistance (for example, because of a short inspiratory 
time during assist/control ventilation) can also result in 
dyssynchrony. Auto-cycling, which results in excessive 
assistance and can be due to excessive triggering sensi-
tivity or leaks, is diﬃ  cult to detect. It may be revealed by 
reducing trigger sensitivity during a short series of ‘test’ 
breaths. Decreasing levels of pressure support and 
increasing expiratory trigger are the most eﬀ ective solu-
tions for ineﬀ ective eﬀ orts, whereas applying some PEEP 
may help but does not always work [55].
Recognizing dyssynchrony is important because it can 
indicate dynamic hyperinﬂ ation and may lead to 
excessive ventilatory assistance [55] and induce delays 
in weaning from mechanical ventilation [56] and severe 
sleep disruption [57]. Th ere is no automatic method to 
detect dyssynchrony. Because of the clinical importance 
of dyssynchrony, one must learn how to recognize it 
from traces on the ventilator (this can be relatively easy, 
at least for gross asynchronies) [56] (Figure  5), and 
improved bedside training of curve reading is needed. 
Electromyo graphy can also be of use in determining the 
presence of dyssynchrony but is rather complex for 
clinical use [58].
Figure 3. Pressure (horizontal axis)-volume (vertical axis) 
loop obtained in a sedated and paralyzed patient with acute 
respiratory distress syndrome (ARDS) by the means of a 
supersyringe with successive small steps of infl ation and 
defl ation. The static pressure volume points are fi tted with an 
S-shaped line with obvious lower and upper infl ections (at 10 and 
25 cm H2O, respectively). The whole loop shows a marked hysteresis, 
and there is an upper defl ation infl ection at about 20 cm H2O. 
Paw, airway pressure.
Vol (L)
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Work of breathing
Work of breathing (WOB) represents the integral of the 
product of volume and pressure. It represents the energy 
associated with a given VT at a given pressure (spon-
taneous, mechanical, or both) [59]. Th e airway pressure 
is the pressure of the whole respiratory system (lungs 
plus chest wall); the transpulmonary pressure is the 
pressure needed to distend the lung parenchyma (airway 
pressure minus the pleural pressure); ﬁ nally, the pleural 
pressure is the pressure needed to distend the chest wall. 
In the clinical/physiological setting, esophageal pressure 
is used as a surrogate for pleural pressure. ‘Work’ is not 
the same as ‘eﬀ ort’ – eﬀ ort without volume generation 
will not result in increased WOB. Normal WOB values 
range between 0.2 and 1 J/L.
In paralyzed patients with mechanical ventila tion, plots 
of airway pressure versus VT indicate the total amount of 
work needed to inﬂ ate the respiratory system (that is, the 
work done by the ventilator on the whole respiratory 
system and the ETT). Th is is not the amount of work 
performed by the respiratory muscles, for which eso pha-
geal (pleural) pressure measurements are needed. One 
also needs to know the slope of the passive P/V curve of 
the chest wall (which denotes the relaxation of the 
respiratory muscles). Th e surface encom passed within 
the passive P/V curve of the chest wall and the negative 
esophageal pressure swing during an inspiratory eﬀ ort is 
shown in the so-called Campbell diagram [60,61]. Finally, 
the two components of work (that is, elastic and resistive) 
can be split by joining the zero ﬂ ow points at the 
beginning and the end of inspiration (Figure  6). Th e 
Campbell diagram allows the true work performed by the 
respiratory muscles to be estimated under diﬀ erent 
clinical conditions, even when auto-PEEP is present 
[60,61].
Calculation of WOB may also be useful in under-
standing weaning failure. Jubran and colleagues [62] 
showed that the esophageal pressure trend during a 
spon taneous breathing trial (SBT) complemented the 
pre dic tion of weaning outcome provided by the frequency/
VT index measured during the ﬁ rst minute of an SBT. 
Monitoring WOB can also theoretically help in titrating 
ventilator support. It could also be used to evaluate the 
eﬀ ects of diﬀ erent ventilatory modes, understand the 
mechanisms of disease (weaning failure, acute asthma, 
and exacer bations of chronic obstructive pulmonary 
disease (COPD)), and evaluate the eﬀ ects of therapeutic 
interven tions (for example, bronchodilators [63]) and the 
inﬂ uence of ventilator performance (triggering, ﬂ ow 
delivery, and so on). Because it requires esophageal 
pressure measurement, this technique has been reserved 
largely for clinical research. It has potential for clinical 
use but few monitors provide bedside calculations.
Occlusion pressure (P0.1)
Th e occlusion pressure, also referred to as P0.1, reﬂ ects 
the respiratory drive to breathe and is correlated to WOB 
for a given patient. Measurements of P0.1, now auto-
matically provided on ventilators, may be useful to assess 
the patient’s response to titration of ventilator settings 
(that is, ﬂ ow rate, PEEP, and so on) and could be used as a 
surro gate of WOB to help titrate pressure support or 
external PEEP in cases of intrinsic PEEP [60,64]. A P0.1 of 
less than 2 cm H2O is considered normal. Th is measure 
has been restricted largely to research. However, because 
the P0.1 is now more widely available in the ICU and is an 
extremely simple and rapid way to estimate central 
respiratory drive, its potential clinical role needs to be 
evaluated.
Pressure-time product
Th e pressure-time product is the integral of the pressure 
performed by the respiratory muscles during inspiration 
or expiration and time or both. Th e pressure-time 
product is an alternative to WOB and has some 
theoretical and practical advantages over WOB calcula-
tions. Th e pressure-time product is asso ciated with 
oxygen consumption by the respiratory muscles [65] and 
could be considered a surrogate to quantify the metabolic 
expense of respiratory eﬀ ort. Since it is independent from 
the ability of the patient to generate volume, the pressure-
time product is relevant in situations in which there is a 
disconnection between eﬀ ort and volume (for example, 
during asynchrony) [66]. Normal values for the pressure-
time product range between 60 and 150 cm H2O/second 
per minute [67].
Transpul monary and esophageal pressure
Transpulmonary pressure is the diﬀ erence in pressure 
between the inside (alveoli) and the outside (pleural 
space) of the lung. Variations in transpulmonary pressure 
Figure 4. Example of a fl ow wave shape typical of expiratory 
fl ow limitation and intrinsic positive end-expiratory pressure 
(PEEP). Qualitative analysis of the expiratory part of the curve 
provides this information. Exp, expiration ; Insp, inspiration.
Insp
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Flow
Flow limitation
High initial exp. flow
Flow interruption
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are the true determinant of lung volume variations 
according to the equation:
ΔVol = ΔPEl,lung × El,lung,
where PEl,lung is transpulmonary pressure and El,lung is the 
elastance of the lung.
In static conditions (that is, no ﬂ ow), the pressure 
inside the lung can be easily estimated from Paw (airway 
pressure), but the pressure outside the lung (that is, the 
pleural pressure, or Ppl) is not easily measurable and must 
be estimated from the esophageal pressure (Pes): PEl,lung = 
Paw – Pes.
For any change in lung volume, the higher the elastance 
of the chest wall (Elcw ), the greater the contribution of the 
Ppl change to the total Paw change. Th e chest wall and the 
lung contribute to the change in airway pressure in 
proportion to their elastance:
ΔPaw = ΔPEl,lung+ ΔPes = ΔVol × El,lung + ΔVol × Elcw = 
ΔVol × (El,lung + Elcw)
PEl,lung is the real eﬀ ector of lung volume changes and of 
potential ventilator-induced lung injury (VILI) and is of 
major importance in the setting of mechanical ventilation 
[68].
Measurement of Pes is not always straightforward, in 
particular when absolute values are used [69], and some 
clinicians ﬁ nd Pes diﬃ  cult to use. Chiumello and colleagues 
[70] recently explored the concept of speciﬁ c elastance, 
which reﬂ ects the intrinsic elastic properties of the lung 
parenchyma and which relates stress (transpulmonary 
pressure) and strain (change in volume relative to 
functional residual capacity (FRC)). Speciﬁ c elastance is 
rather constant among patients with ARDS (and even 
healthy subjects) and thus the measurement of end-
expiratory lung volume (EELV) could allow an eﬀ ective 
evaluation of the PEl,lung change caused by VT; that is, once 
the strain is measured, it is possible to infer the stress. Th e 
concept that the risk of VILI can be related to the ratio 
between VT and EELV has been suggested by positron 
emission tomography studies in patients with ARDS [71].
Figure 5. Example of ineff ective eff orts demonstrated on the esophageal pressure analysis. These missing eff orts can be easily recognized 
on the airway pressure trace and the fl ow trace as indicated by the arrows. Id, idem.
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Speciﬁ c problems arise from the fact that the ARDS 
lung is non-homogeneous, and some areas, possibly 
entire lobes, are not exposed to airway pressure because 
of collapse, whereas the boundary regions between 
ventilated and collapsed areas may be exposed to high 
distending pressures, potentially causing VILI. Attention 
should also be paid when applying these concepts to 
assisted rather than controlled breathing conditions [72]. 
Th e pressure developed by the inspiratory muscles and 
by the diaphragm may cause negative swings in pleural 
pressure, bringing the transpulmonary pressure to levels 
well beyond the VILI threshold. Th e eﬀ ects of huge 
inspiratory eﬀ orts have only occasionally been investi-
gated in patients with ARDS [73] but are known to cause 
lung edema in the experimental animal and in airway-
obstructed patients. Decreased pleural pressure has been 
shown to be associated with cardiovascular failure during 
weaning [74], possibly because of increased trans-
diaphrag matic pressure and right heart overload [75].
In clinical practice, transpulmonary pressure estimate 
poses two problems. First, like WOB and the pressure-
time product, it requires correct placement of an eso-
phageal probe. Th e availability of nasogastric feeding 
tubes with esophageal balloons should greatly facilitate 
the use of these techniques. Second, ensuring the validity 
of the absolute value of esophageal pressure in a supine 
patient for estimating end-inspiratory or end-expiratory 
transpulmonary pressure values remains diﬃ  cult.
Abdominal pressure
Increased intra-abdominal pressure (IAP) can decrease 
compliance of the lung and chest wall and increase dead 
space and shunt fraction (Qs/Qt). Increased IAP reduces 
the impact of trans pulmonary pressure as the driving 
force for alveolar opening and prevention of closing. 
Th ere is some relation ship between abdominal and pleural 
pressures. IAP can be assessed fairly simply by using a 
bladder catheter [76], and given that high IAPs can have 
conse quences in terms of diagnosis and management, 
more regular measurement of IAP is recommended.
3. Lung volumes
Direct measurement of end-expiratory lung volume
ARDS is associated with a marked reduction in lung 
volume [77]. Monitoring of FRC can provide information 
to assess pulmonary function. When the closed dilution 
technique is used, the patient breathes in a ﬁ xed 
concentration of helium or methane mixed with oxygen 
and the concentration in the expired breath can be used 
to calculate the FRC. Th is technique is used for research 
purposes. An alternative approach is a washout/washin 
technique using nitrogen or oxygen. Olegard and 
colleagues [78] reported that, by changing the FiO2 
abruptly by as little as 0.1, the FRC could be calculated by 
using standard gas-monitoring equipment. Th e precision 
of this method seems acceptable, and the method can be 
used even in the most severely hypoxemic patients 
[79,80].
FRC is sex-, length-, and age-dependent. Ibanez and 
Raurich [81] showed that FRC decreased by 25% after 
changing the position from sitting to supine in healthy 
volunteers. Bikker and colleagues [82] found a reduction 
of 34% in mechanically ventilated patients with ‘healthy’ 
lungs and attributed this to the loss of muscle tension 
with sedation in ICU patients. In critically ill patients 
receiving mechanical ventilation and diﬀ erent levels of 
Figure 6. Campbell diagram with all of its components. The 
horizontal axis shows the esophageal pressure (the surrogate of 
pleural pressure), and the vertical axis denotes volume above end-
expiration. The fi tted points to the left of the red line indicate the 
decrease in esophageal pressure during inspiration, and the points 
to the right of the red line indicate the esophageal pressure during 
expiration. The red line joins the points of zero fl ow at the beginning 
and the end of inspiration. The continuous black line to the right 
of the diagram denotes the chest wall compliance when muscles 
are relaxed, and the parallel dotted line joining the zero fl ow point 
at the beginning of inspiration is used to account for the presence 
of intrinsic positive end-expiratory pressure (PEEP) (the horizontal 
distance between the continuous and the dotted black lines). The 
surface to the left of the red line is the resistive component of work, 
and the surface to the right of this red line is the elastic component 
of work, including the elastic component of work due to the 
presence of intrinsic PEEP (about 3 cm H2O in this example). The 
elastic work due to the intrinsic PEEP is the surface of the rectangle 
with base equal to intrinsic PEEP (the horizontal distance between 
the continuous and the dotted black lines) and height equal to tidal 
volume (about 360 mL in the example). Pes, esophageal pressure.
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PEEP, it is better to speak of EELV [83]. Application of 
PEEP leads to increased EELV values as a result of 
recruit ment or further distention of already ventilated 
alveoli. To diﬀ erentiate between recruitment and 
distention, EELV changes can be combined with 
compliance values [82]. From the compliance calculation, 
one can determine the expected change in EELV for a 
given change in PEEP. If application of PEEP leads to a 
higher EELV, this method can be used to estimate 
alveolar recruitment at the bedside [84]. Measurement of 
EELV has been made available recently for routine use. 
Although we still have limited experience with this 
technique, it has considerable potential, at least in the 
management of patients with ARDS.
Chest ultrasonography and computed tomography
Chest ultrasonography can be useful at the bedside for 
early identiﬁ cation of edema as well as other abnor-
malities like pneumothorax or pleural eﬀ usion [85,86]. 
However, this technique requires training. Recently, it 
was shown that lung ultrasonography can be used to 
estimate alveolar reaeration in patients treated for 
ventilator-associated pneumonia [87] and to estimate 
PEEP-induced lung recruitment [88]. Th is is a relatively 
new but promising and non-invasive technique that 
could have important clinical applications in the ICU.
Computed tomography (CT) scanning can be useful to 
identify ongoing pathology. CT images can be used to 
compute average lung density and quantitate the respec-
tive amounts of air and tissue, but this approach is 
currently restricted to research [42,89]. CT could poten-
tially have roles in guiding protective mechanical ventila-
tion in ARDS and in appropriately setting VT and PEEP 
[90]. Th e major limitations are the need to transfer the 
patient to the CT scanner and the complex processing 
needed for analysis.
Electrical bioimpedance tomography
In electrical bioimpedance tomography (EIT), a current 
is applied via 16 electrodes positioned around the thorax. 
A scan of the impedance to ﬂ ow in a slice of the thorax 
reﬂ ects changes in aeration but gives no information on 
EELV and measures only relative impedance without 
providing absolute values. Images can be subdivided into 
several regions and can be used to monitor regional 
ventilation. EIT can be used to show whether a recruit-
ment maneuver has been successful and document the 
eﬀ ects of positioning and of PEEP application [91,92].
Th e caudal thoracic level above the diaphragm is of 
particular importance because atelectasis due to mecha-
nical ventilation can be expected at this level. Various 
studies have described ventilation distribution change 
maps to evaluate lung collapse or overdistension [93-95]. 
Costa and colleagues [93] introduced an algorithm for 
estimating recruitable alveolar collapse by using EIT. 
Bikker and colleagues [94] clearly visualized improve-
ment or loss of ventilation in dependent and non-
dependent parts of the lung by using EIT measurements 
in ICU patients. When EIT was used at multiple levels in 
mechanically ventilated patients, ventilation distribution 
was shown to shift from the dorsal to ventral region but 
also from the caudal to cranial level during a decremental 
PEEP trial [95].
Th e increase in airway pressure during normal 
inspiration is followed by a continuous redistribution of 
gas from non-dependent to dependent regions. Th us, 
during the initial phase of inspiration, most of the 
inspiratory gas goes to the non-dependent lung, and 
during the last parts of inspiration, the most dependent 
parts receive the inspiratory ﬂ ow, especially in patients 
with a positive response to a recruitment maneuver. Th is 
technique may thus represent a means of identifying 
responders and non-responders to recruitment during 
normal tidal ventilation, enabling one to avoid exposing 
non-responders to high-pressure recruitment maneuvers. 
Additional clinical work is now needed to delineate the 
place of EIT in the ICU as a qualitative tool to visualize 
ventilation distribution or as a quantitative technique to 
estimate the eﬀ ects of interventions.
4. Cardiopulmonary interactions
Hemodynamic monitoring
Th e use of hemodynamic monitoring in the unstable 
critically ill patient was reviewed recently [96]. Hemo-
dynamic monitoring is particularly helpful during diﬃ  -
cult weaning processes to separate cardiac from pulmo-
nary aspects of failed weaning. Th e heart may not be able 
to meet the increased oxygen demand during weaning 
and then cardiac ﬁ lling pressures generally increase and 
the mixed venous oxygen saturation (SvO2) (or central 
venous oxygen saturation) decreases. SvO2 is a rather 
non-speciﬁ c but sensitive kind of monitoring, as its 
changes reﬂ ect a change in one or more of the major 
homeostatic systems (respiration, circulation, and energy 
demand). During the weaning process, a reduction in 
SvO2 may be expected as spontaneous breathing 
represents a form of exercise, but a decrease in SvO2 may 
reﬂ ect the inability of the heart to face the increased 
oxygen demand, especially if arterial hypertension is 
present [97].
Echocardiographic evaluation may be helpful in acute 
respiratory failure, simply to identify a dilated right 
ventricle (RV) or RV failure, which may necessitate a 
decrease in PEEP or VT (or both) to reduce RV afterload. 
Measurement of pulmonary artery pressure can also be 
reliably obtained by Doppler measurements [98]. Echo-
graphy can be particularly helpful just before a suspected 
diﬃ  cult SBT and sometimes during the SBT. Patients at 
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risk of weaning failure were identiﬁ ed as having decreased 
ejection fraction and increased ﬁ lling pressures before 
SBT [99]. Echo can help to estimate pulmonary artery 
occlusion pressure elevation during SBT. Th e limitations 
of echocardiography are that it requires some training 
and is time-consuming, but it is an increasingly useful 
tool for cardiorespiratory monitoring in the ICU.
Cardiac biomarkers, like B-type natriuretic protein 
(BNP) or N-terminal prohormone of BNP (NT-proBNP), 
may be useful for diagnosing heart dysfunction but also 
for monitoring purposes, especially during weaning from 
mechanical ventilation [100,101].
5. Lung infl ammation
Bronchoalveolar lavage studies
Bronchoalveolar lavage (BAL) can be used to assess 
hemorrhage and measure neutrophils, eosinophils, hyaline 
membranes, lipid inclusion, and cancer cells (although 
this requires a careful cytologic examination of the 
alveolar ﬂ uid sampled). BAL ﬁ brocyte levels are elevated 
in ARDS and related to outcome, and levels higher than 
6% were observed in non-survivors [102]. BAL ﬂ uid 
analysis may also help to identify patients who may 
respond to steroids. Many studies have shown higher 
levels of inﬂ ammatory mediators (cytokines and so on) in 
BAL ﬂ uid of non-survivors than survivors of ARDS. 
Measuring cytokines or phosphorylation products may 
help to identify VILI, but there is a high signal-to-noise 
ratio at present. Among the limitations of BAL ﬂ uid 
analysis are that it needs an endoscope and requires some 
training, and there is no standardized technique (depends 
on the volume instilled and amount of ﬂ uid returned). A 
potential complication is hypoxemia. Detailed BAL 
analy sis is suitable for bacteriological purposes, but 
detailed cytological or biomarker assessment is often 
reserved for clinical trials.
Respiratory monitoring in specifi c situations
Respiratory monitoring in acute respiratory distress 
syndrome
As already mentioned, assessment of the severity of 
ARDS should include not only oxygenation but also dead 
space estimate and lung mechanics. Monitoring of plateau 
pressure, as a reﬂ ection of the maximal alveolar pressure, 
is essential. Potentially important tools for the most 
severe patients include esophageal pressure and lung 
volume measurements. P/V curves with assessment of 
recruitability could also be potentially useful. EVLW 
estimates may help in diﬀ erential diagnosis.
Respiratory monitoring in chronic obstructive pulmonary 
disease/asthma
In the initial phase of mechanical ventilation, a detailed 
assessment of respiratory mechanics, including plateau 
pressure and auto-PEEP, is essential to characterize the 
patient. When patients are switched to triggered breaths, 
detection of asynchrony is very useful in titrating 
ventilator assistance.
Respiratory monitoring in non-invasive ventilation
Respiratory monitoring in patients receiving non-
invasive ventilation (NIV) should start with a full clinical 
assessment: dyspnea, respiratory muscle function, com-
fort, mental alertness, and gastric distention are impor-
tant signs. Th ese clinical indicators should then be com-
bined with additional objective variables for a full evalua-
tion of respiratory status. Pulse oximetry is essential but 
does not provide information about PCO2. Expired CO2 
can be measured (from the mask or helmet), but leaks 
often make these measurements unreliable. Transcu-
taneous capnometry oﬀ ers a continuous and non-
invasive method of monitoring alveolar ventilation [103]. 
Arterial blood gases remain important in assessing the 
response to therapy.
Patient-ventilator asynchrony occurs in almost one half 
of patients and may be related largely to leaks [104]. 
Clinical evaluation (tachypnea, accessory muscle activity, 
agitation, and lack of cooperation) or waveform analysis 
can be useful in assessing the presence of patient-
ventilator dyssynchrony. Electromyography tracings are 
cumbersome, but airway pressures and ﬂ ows can be used 
to monitor patient eﬀ orts and identify ‘autotriggering’, 
premature cycling, or ineﬀ ective triggering [105]. 
Inspired and expired VT values can help to identify air 
leaks.
In the hypoxemic patient, respiratory monitoring 
should also help to identify when to intubate the trachea 
(not too late!). Shock, including measurement of blood 
lactate levels, should also be looked for since the presence 
of acute circulatory failure is an exclusion criterion for 
NIV [106].
Respiratory monitoring in the neurological patient
Neurological dysfunction is one of the most frequent 
reasons for initiating mechanical ventilation [107]. Out-
comes of critically ill neurological patients are driven 
mainly by the underlying neurological pathology [108,109], 
and the inﬂ uence of extracerebral organ dysfunction and 
ventilatory management on outcomes in this group of 
patients is not well established [110].
In mechanically ventilated neurological patients, no 
consensus has been reached about optimal VT, PEEP, 
PaO2, or PaCO2 levels [111], largely because these 
patients have been universally excluded from randomized 
trials of lung-protective ventilation because of concerns 
about potential intracranial pressure (ICP) increases due 
to hypercapnia or increased thoracic pressures. More-
over, owing to persistently decreased levels of 
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conscious ness, typical weaning and liberation techniques 
used in medical-surgical ICU patients may not apply to 
this group [109,112]. Finally, tracheostomy is commonly 
imple mented as part of the management of these 
neurological patients, but the technique of choice and 
timing are controversial [109].
Pulmonary hyperventilation rapidly reduces ICP by 
reducing cerebral blood ﬂ ow (CBF). Th e eﬀ ect on ICP is 
not sustained, whereas CBF may remain low, raising risks 
of ischemia [113,114]; hyperventilation should, therefore, 
be avoided during the ﬁ rst 24  hours after injury, when 
CBF is often already low [115]. Th e CBF level at which 
irreversible ischemia occurs has not been clearly estab-
lished, but ischemic cell change has been demonstrated 
following traumatic brain injury and is likely to occur 
when CBF decreases to less than 15 to 20 mL/100 g per 
minute. Hyper ventilation should, therefore, be used only 
for short-term management of raised ICP and only in 
patients with life-threatening intracranial hypertension 
[115,116]. If hyper venti lation is used, jugular venous 
oxygen saturation (SjO2) or brain tissue oxygen tension 
(PbrO2) monitoring should be used to evaluate oxygen 
delivery where possible [115]. Th e ideal value for PaCO2 
is one that keeps ICP to less than 20 mm Hg and cerebral 
extraction of oxygen (CEO2) to between 24% and 42% to 
avoid brain ischemia.
Moderate levels of PEEP (for example, less than 
15 cm H2O) can be safely used in patients with cerebral 
lesions, mainly in those with low pulmonary compliance 
[117]. Hence, although care should be taken when 
applying PEEP in patients with neurological injury, it 
should not be withheld if needed to maintain adequate 
oxygenation [114].
Multimodal brain monitoring, including brain tissue 
oxygen tension, CBF measurement, and intracerebral 
microdialysis (with measurement of lactate, pyruvate, 
glutamate, glycerol, and inﬂ ammatory mediators), may 
be useful to optimize mechanical ventilation in patients 
with severe brain injury [118].
Conclusions and perspectives
Although most of the clinical interventions applied to the 
respiratory system of the critically ill are relatively simple, 
they are often misused, largely as a result of a poor 
understanding of the physiology under lying a speciﬁ c 
intervention or of its consequences on the patho physio-
logy of respiratory disease or both. We need to encourage 
increased training in these techniques guided by a better 
knowledge of underlying mechanisms and appropriate 
use and correct interpretation of the data provided by 
available monitoring techniques.
Importantly, two key concepts can be highlighted:
1. Multiple variables need to be integrated: Many 
critically ill patients with respiratory failure have 
complex pathologies, and the respiratory failure is part 
of a broader multiple organ failure. Management will, 
therefore, require the consideration of monitored data 
from several diﬀ erent systems. Th is is one reason why 
it is diﬃ  cult to develop protocols for the use of 
mechanical ventilation.
2. Monitoring of solitary static values provides limited 
information; evaluation of dynamic changes in 
variables over time is more important.
Th e future is likely to see advances in neuro-ventilatory 
coupling to limit the occurrence and adverse eﬀ ects of 
patient-ventilator asynchrony. Biomarker panels will be 
developed to determine the risk of ARDS and VILI and to 
guide therapy. Chest ultrasonography and other, less 
invasive techniques will also be used more as they 
become more readily available at the bedside and training 
is improved.
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